Experimental Data Snapshot
Starting Model:experimental
View more details
(2011) Nat Struct Mol Biol 18: 604-613
ERAP1 trims antigen precursors to fit into MHC class I proteins. To fulfill this function, ERAP1 has unique substrate preferences, trimming long peptides but sparing shorter ones. To identify the structural basis for ERAP1's unusual properties, we determined the X-ray crystal structure of human ERAP1 bound to bestatin. The structure reveals an open conformation with a large interior compartment. An extended groove originating from the enzyme's catalytic center can accommodate long peptides and has features that explain ERAP1's broad specificity for antigenic peptide precursors. Structural and biochemical analyses suggest a mechanism for ERAP1's length-dependent trimming activity, whereby binding of long rather than short substrates induces a conformational change with reorientation of a key catalytic residue toward the active site. ERAP1's unique structural elements suggest how a generic aminopeptidase structure has been adapted for the specialized function of trimming antigenic precursors.
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (BES) |Predict Membrane
Biological assembly 1 assigned by authors and generated by PISA (software)
Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (BES) |Predict Membrane
Biological assembly 2 assigned by authors and generated by PISA (software)
Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (BES) |Predict Membrane
Biological assembly 3 assigned by authors and generated by PISA (software)
Macromolecule Content
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Endoplasmic reticulum aminopeptidase 1 | 921 | Homo sapiens | Mutation(s): 0 Gene Names: ERAP1, APPILS, ARTS1, KIAA0525, UNQ584/PRO1154 EC: 3.4.11 Membrane Entity: Yes | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for Q9NZ08 (Homo sapiens) Explore Q9NZ08 Go to UniProtKB: Q9NZ08 | |||||
PHAROS: Q9NZ08 GTEx: ENSG00000164307 | |||||
Entity Groups | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | Q9NZ08 | ||||
Glycosylation | |||||
Glycosylation Sites: 3 | Go to GlyGen: Q9NZ08-1 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Length | 2D Diagram | Glycosylation | 3D Interactions |
alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | D, F | 5 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan: G22768VO GlyCosmos: G22768VO GlyGen: G22768VO |
Ligands 3 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
BES Query on BES Download Ideal Coordinates CCD File | H [auth A], L [auth B], O [auth C] | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID C16 H24 N2 O4 VGGGPCQERPFHOB-RDBSUJKOSA-N | |||
NAG Query on NAG Download Ideal Coordinates CCD File | I [auth A], J [auth A], M [auth B] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
ZN Query on ZN Download Ideal Coordinates CCD File | G [auth A], K [auth B], N [auth C] | ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 71.029 | α = 90 |
b = 234.635 | β = 103.59 |
c = 95.86 | γ = 90 |
Software Name | Purpose |
---|---|
DENZO | data reduction |
SCALEPACK | data scaling |
PHASER | phasing |
RESOLVE | phasing |
PHENIX | refinement |
PDB_EXTRACT | data extraction |
CBASS | data collection |
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729.